Search by Drug Name or NDC

NDC 00527-1242-02 Fludarabine Phosphate 25 mg/mL Details

Fludarabine Phosphate 25 mg/mL

Fludarabine Phosphate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is FLUDARABINE PHOSPHATE.

MedlinePlus Drug Summary

Fludarabine injection is used to treat chronic lymphocytic leukemia (CLL; a type of cancer of the white blood cells) in adults who have already been treated with at least one other medication and have not gotten better. Fludarabine injection is in a class of medications called purine analogs. It works by slowing or stopping the growth of cancer cells in your body.

Related Packages: 00527-1242-02
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Fludarabine Injection

Product Information

NDC	00527-1242
Product ID	0527-1242_1b10ebb9-8a76-41c8-bf18-166e54471b0d
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Fludarabine Phosphate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Fludarabine Phosphate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAVENOUS
Active Ingredient Strength	25
Active Ingredient Units	mg/mL
Substance Name	FLUDARABINE PHOSPHATE
Labeler Name	Lannett Company, Inc.
Pharmaceutical Class	Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA090724
Listing Certified Through	2024-12-31

Package

NDC 00527-1242-02 (00527124202)

Pricing Information	N/A
NDC Package Code	0527-1242-02
Billing NDC	00527124202
Package	1 VIAL, SINGLE-DOSE in 1 CARTON (0527-1242-02) / 2 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date	2019-12-31
NDC Exclude Flag	N